INS and familial pancreatic carcinoma: Insulin resistance due to kinase/mTOR inhibitors or corticosteroids needs to be treated with insulin sensitizers, and insulin deficiency due to immunotherapy or post-pancreatitis/pancreatic cancer needs mandatory supplementation of insulin (6).